evidence, cost-effectiveness and controversies, surrounding the nonsurgical treatment of localised prostate cancer, with a focus on radiation and endocrine therapies, and to discuss the role of magnetic resonance spectroscopy, as a decision tool for multimodality treatment design and prediction of response...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Over the past two decades, serum PSA screening has provided a valuable tool for prostate cancer surveillance, however the age-adjusted incidence of mortality has remained relatively constant, therefore new tools are needed to guide prognosis and treatment. Research into the genetic origins of prostate...
Decipher Prostate is a tissue-based genomic test that provides actionable information for treatment decision-making across the spectrum of localized prostate cancer. Learn moreabout Decipher Prostate Decipher Bladder is the only commercially available genomic subtyping tool for patients with bladder cancer ...
only illuminated one facet of a complex decision. There is more to a treatment decision than just the side effects, the most obvious being the effectiveness of the treatment, and that is something we hope to be able to demonstrate as we are now funded to look at 10-year cancer outcomes....
Bhatnagar V, Frosch DL, Tally SR, Hamori CJ, Lenert L, Kaplan RM. Evaluation of an internet-based disease trajectory decision tool for prostate cancer screening. Value Health. 2009;12(1):101-8.Bhatnagar V, Frosch DL, Tally SR, et al. Evaluation of an Internet-Based Disease Trajectory ...
machine-learning algorithms can automatically identify suspect lesions, distinguishing indolent from csPCa and ultimately assessing preoperative extracapsular extension with an accuracy of 83.58% compared to the prostatectomy specimen [40], thus serving as a decision support tool regarding further treatment....
"Watch and wait," is a phrase that is being used more frequently to describe a program of active surveillance without other cancer treatment for some patients with prostate cancer. It means that if your cancer is not aggressive (based on the Gleason score and the cancer stage), treatments ma...
It is of exceptional interest to find out whether a similar mechanism could be active in prostate cancer. Methylation as a diagnostic tool can be utilized for rare morphological forms of prostate cancer. The analysis of DNA methylation patterns from 48 patients, including 9 with neuroendocrine PC ...